|Videos|April 20, 2022
The Top 3 Technological Challenges in Decentralized Trials
Author(s)IQVIA
Nagaraja Srivatsan, SVP & Chief Digital Officer at IQVIA, breaks down the most recent challenges in the decentralized trial space: patient burden, the ecosystem between the patient and information, and the global regulatory landscape.
- The harmony of decentralized trials is when site, sponsor, and patient come together.
- There is no one size fits all for technological adaptations when it comes to the patient.
- Regulations for data flow, GDPR, patient privacy, and more are constantly coming in, and must be adhered to.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
2
Artificial Intelligence in Clinical Trials: From Pilots to Practice
3
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5